Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report

Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report

Abstract Background Tracheobronchial malignant stenosis is a life-threatening condition which may cause recurrent infections due to lung atelectasis. Despite immunotherapy is less toxic than standard chemotherapy, recurrent lung infections may represent a challenge for this treatment. We report a cl...

Full description

Bibliographic Details
Main Authors: Alfonso Fiorelli, Fabio Perrotta, Mariano Mollica, Mario Santini, Fabiana Vitiello, Marina Gilli, Cecilia Calabrese, Andrea Bianco
Format: Article
Language:English
Published: BMC 2019-03-01
Series:Journal of Cardiothoracic Surgery
Subjects:
Endoscopic airway recanalization
Pembrolizumab
Immunotherapy
NSCLC
PD-L1
Online Access:http://link.springer.com/article/10.1186/s13019-019-0862-6

Internet

http://link.springer.com/article/10.1186/s13019-019-0862-6

Similar Items